Pricing Log in Create free account

Evommune Inc. (EVMN) vs Vanda Pharmaceuticals Inc. (VNDA)

Evommune Inc. and Vanda Pharmaceuticals Inc. are both Biotechnology companies. Evommune Inc. and Vanda Pharmaceuticals Inc. are of similar size ($241.3M and $231.0M). Evommune Inc. has the higher net margin (0.00% vs −119.9%) and the higher return on invested capital (−82.5% vs −180.2%). Across the 13 metrics below, Evommune Inc. leads on 9 and Vanda Pharmaceuticals Inc. on 4.

Valuation

Metric EVMN VNDA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1.01 9.40
P/B 0.87 1.16 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 0.40 9.02
Earnings yield (165.86%) (121.02%) (32.88%)
Free cash flow yield (31.07%) (64.93%) (23.13%)

Profitability

Metric EVMN VNDA Biotechnology median
Gross margin — 93.59% 68.51%
Operating margin 0.00% (77.59%) 0.00%
Net margin 0.00% (119.87%) 0.00%
Free cash flow margin 0.00% (65.41%) 0.00%
Return on equity (141.99%) (82.55%) (51.96%)
Return on assets (62.71%) (55.89%) (46.06%)
Return on invested capital (82.46%) (180.19%) 0.00%

Growth

Metric EVMN VNDA Biotechnology median
Revenue growth (TTM) — 8.11% 6.76%
EPS growth (last fiscal year) 75.23% (1,033.33%) 29.88%
Revenue growth, 5-year CAGR — (2.73%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EVMN VNDA Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 11.68 1.54 4.97
Net debt to EBITDA 1.87 1.84 1.01

Dividend

Metric EVMN VNDA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EVMN VNDA Biotechnology median
Market cap 241.34m 230.99m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack